Previous scientific evidence has shown a relationship between hormones and the onset and relapse of perinatal psychotic disorders (PPD) in women during pregnancy, childbirth, and the postpartum period. In healthy women the interaction between hormones and cognitive changes has been confirmed mainly in memory, attention, and executive function during pregnancy and postpartum, which respond to adaptive demands related to parenting tasks. In women with psychotic episodes there is a significant impairment in several cognitive functions, but studies of the perinatal period are limited. The objective of this mini review is to analyze the main findings to identify whether hormonal changes interact with the onset of PPD and cognitive impairment in perinatal women. The studies included samples of women with psychosis, risk of developing psychosis, bipolar psychosis, schizoaffective psychosis, and psychotic symptoms, during pregnancy and postpartum. Findings contributed to knowledge about five hypotheses regarding the relationship between hormones in the perinatal period and the appearance of PPD. Nevertheless, this review did not find reports of evidence of a relationship between hormonal production and cognitive function among women with clinically diagnosed PPD, suggesting a research gap. Clinical implications of assessing hormonal production and cognitive function in PPD are discussed. Although the evidence identified is scarce and heterogeneous, the findings call for further research with clinical samples on the role of hormones in perinatal psychotic disorders, especially as they relate to the study of cognition. This will promote more consistent evidence and understanding of PPD etiopathology that can guide early and effective multidisciplinary interventions.

Many gender differences in mental and physical health, along with accompanying social needs have been reported by those suffering with schizophrenia. The goal of this review is to explore the literature on migrant and culturally diverse women suffering with schizophrenia to develop and implement effective strategies in specialized clinics. In general, we found higher rates of mental health symptoms among migrant and refugee women when compared to men. Several factors contribute to this vulnerability, suggesting that women may experience more pre- and post-migration-related trauma. In clinical populations, migrant status, region of origin, age at the time of migration, migration with family or alone, and migration to join family determine the risk of schizophrenia and the clinical course of the illness. Refugee migrant women have a higher risk of schizophrenia than non-refugee migrants and native-born populations. Migration is associated with poor access to mental health services; low social support, lack of awareness of services, and language barriers may mediate this association. These findings call for specific assessments on migrant women, interventions (e.g., focus groups), and improvement in current programs. In our clinics, we have recently incorporated assessment and intervention strategies that may be effective in our programming.

Introducción: El modelo económico actual que originalmente busca maximizar la productividad para mejorar los estándares de vida, inevitablemente ha contribuido al desequilibrio entre la vida laboral y familiar. Objetivo: Realizar una revisión de la literatura sobre la jornada laboral y su relación con el estrés y conflicto trabajo-familia en trabajadores de Latinoamérica. Metodología: Se consultaron cinco bases de datos Dialnet, Redalyc, Pudmed, ScienceDirect y Scielo para identificar estudios publicados en el periodo de 2014-2024. Resultados: Se obtuvieron ocho referencias finales publicadas en seis países de la región. Los hallazgos señalan que las jornadas laborales prolongadas tienen una serie de consecuencias a nivel organizacional y familiar, e incluyen la reducción del tiempo dedicado a la familia y el deterioro de las relaciones interpersonales familiares modulados por el estrés. Conclusión: Debido a la escasez de publicaciones y la diversidad metodológica, se concluye que es importante aumentar el estudio sobre el tema en esta región y avanzar en la homogeneización de la metodología para investigarlo.

Women with schizophrenia have specific reproductive and fertility care needs that differ from those of men. This narrative review aims to explore the reproductive and fertility care needs of women with schizophrenia related to fertility, menstrual cycle, family planning, and the perinatal period. Hormonal fluctuations in the menstrual cycle can significantly affect clinical symptoms and the efficacy of contraceptive treatments in women with schizophrenia. When undergoing fertility treatment, attention should be given to the potential interactions between fertility treatment drugs and antipsychotics, as well as the potential impact of antipsychotics on the ability to conceive. Although pregnancy rates and participation in fertility programs have increased among women with schizophrenia, very little information is available on the safety and efficacy of fertility treatments in women with severe psychotic disorders. This is an area that warrants further study. Mobilizing social supports and optimizing medication are important components of the treatment of schizophrenia in the perinatal period and are important for the health and safety of infants and mothers. In conclusion, preventing relapse and promoting physical and mental health in this group of women during successive reproductive periods of life is vital and requires an emphasis on the social and psychiatric context, as well as the biological changes occurring at these times.